Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery

Clinical Trial ID NCT01612546

PubWeight™ 2.39‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01612546

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical Translation of Nanomedicine. Chem Rev 2015 0.93
2 CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing. Proc Natl Acad Sci U S A 2016 0.82
3 Advances in the use of nanocarriers for cancer diagnosis and treatment. Einstein (Sao Paulo) 2016 0.75
Next 100